PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan
MRVI vs. SCHD
Performance
Return for Risk
Drawdowns
Volatility
Dividends

MRVI vs. SCHD

Last updated Jun 4, 2026

MRVI (Maravai LifeSciences Holdings, Inc.) is a stock, while SCHD (Schwab U.S. Dividend Equity ETF) is Dividend fund tracking the Dow Jones U.S. Dividend 100 Index. Over the past 5 years, MRVI returned -35.31%/yr vs 8.36%/yr for SCHD. At a 0.28 correlation, their price movements are largely independent.

Performance

MRVI vs. SCHD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Maravai LifeSciences Holdings, Inc. (MRVI) and Schwab U.S. Dividend Equity ETF (SCHD). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, MRVI achieves a 48.92% return, which is significantly higher than SCHD's 19.01% return.

MRVI

1D
0.21%
1M
27.70%
YTD
48.92%
6M
37.89%
1Y
118.02%
3Y*
-28.66%
5Y*
-35.31%
10Y*
—

SCHD

1D
0.00%
1M
2.70%
YTD
19.01%
6M
18.63%
1Y
27.16%
3Y*
15.09%
5Y*
8.36%
10Y*
12.77%
*Multi-year figures are annualized to reflect compound growth (CAGR)

MRVI vs. SCHD - Yearly Performance Comparison

2026 (YTD)202520242023202220212020
MRVI
Maravai LifeSciences Holdings, Inc.		48.92%-40.37%-16.79%-54.23%-65.85%49.38%-6.03%
SCHD
Schwab U.S. Dividend Equity ETF		19.01%4.34%11.66%4.54%-3.26%29.87%4.65%

Correlation

The correlation between MRVI and SCHD is 0.34, which is low. Their price movements are largely independent, making them effective diversification partners.

Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.34

Correlation (3Y)
Calculated over the trailing 3-year period

0.30

Correlation (5Y)
Calculated over the trailing 5-year period

0.30

Correlation (All Time)
Calculated using the full available price history since Nov 23, 2020

0.28

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Maravai LifeSciences Holdings, Inc.

Schwab U.S. Dividend Equity ETF

Often compared with MRVI:
MRVI vs. MRNAMRVI vs. ARESMRVI vs. EQQQ.LMRVI vs. SPYMRVI vs. AMZNMRVI vs. ADYEYMRVI vs. AAPL
Often compared with SCHD:
SCHD vs. VOOSCHD vs. VYMSCHD vs. SPYSCHD vs. SCHGSCHD vs. JEPISCHD vs. FDVVSCHD vs. VIG

Return for Risk

MRVI vs. SCHD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
MRVI
MRVI Risk / Return Rank: 8383
Overall Rank
MRVI Sharpe Ratio Rank: 8383
Sharpe Ratio Rank
MRVI Sortino Ratio Rank: 8383
Sortino Ratio Rank
MRVI Omega Ratio Rank: 7979
Omega Ratio Rank
MRVI Calmar Ratio Rank: 8787
Calmar Ratio Rank
MRVI Martin Ratio Rank: 8585
Martin Ratio Rank
SCHD
SCHD Risk / Return Rank: 8080
Overall Rank
SCHD Sharpe Ratio Rank: 7575
Sharpe Ratio Rank
SCHD Sortino Ratio Rank: 8484
Sortino Ratio Rank
SCHD Omega Ratio Rank: 7373
Omega Ratio Rank
SCHD Calmar Ratio Rank: 9191
Calmar Ratio Rank
SCHD Martin Ratio Rank: 7575
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MRVI vs. SCHD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Maravai LifeSciences Holdings, Inc. (MRVI) and Schwab U.S. Dividend Equity ETF (SCHD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

MRVISCHDDifference
Sharpe ratioReturn per unit of total volatility
1.63
2.49

-0.86

Sortino ratioReturn per unit of downside risk
2.57
3.87

-1.30

Omega ratioGain probability vs. loss probability

1.29

1.45

-0.15

Calmar ratioReturn relative to maximum drawdown

3.97

5.91

-1.95

Martin ratioReturn relative to average drawdown

8.88

14.53

-5.65

Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

MRVI vs. SCHD - Sharpe Ratio Comparison

The current MRVI Sharpe Ratio is 1.63, which is lower than the SCHD Sharpe Ratio of 2.49. The chart below compares the historical Sharpe Ratios of MRVI and SCHD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Loading charts...

Sharpe Ratios by Period

MRVISCHDDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.63

2.49

-0.86

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.47

0.58

-1.06

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

—

0.77

—

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.38

0.86

-1.24

Drawdowns

MRVI vs. SCHD - Drawdown Comparison

The maximum MRVI drawdown since its inception was -97.16%, which is greater than SCHD's maximum drawdown of -33.37%. Use the drawdown chart below to compare losses from any high point for MRVI and SCHD.

Loading charts...

Drawdown Indicators

MRVISCHDDifference

Max Drawdown

Largest peak-to-trough decline

-97.16%

-33.37%

-63.79%

Max Drawdown (1Y)

Largest decline over 1 year

-29.93%

-4.61%

-25.32%

Max Drawdown (3Y)

Largest decline over 3 years

-88.25%

-16.13%

-72.12%

Max Drawdown (5Y)

Largest decline over 5 years

-97.16%

-16.85%

-80.31%

Max Drawdown (10Y)

Largest decline over 10 years

—

-33.37%

—

Current Drawdown

Current decline from peak

-92.02%

-1.40%

-90.62%

Average Drawdown

Average peak-to-trough decline

-67.60%

-3.32%

-64.28%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.34%

1.88%

+11.46%

Volatility

MRVI vs. SCHD - Volatility Comparison

Maravai LifeSciences Holdings, Inc. (MRVI) has a higher volatility of 24.44% compared to Schwab U.S. Dividend Equity ETF (SCHD) at 2.66%. This indicates that MRVI's price experiences larger fluctuations and is considered to be riskier than SCHD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading charts...

Volatility by Period

MRVISCHDDifference

Volatility (1M)

Calculated over the trailing 1-month period

24.44%

2.66%

+21.78%

Volatility (6M)

Calculated over the trailing 6-month period

43.54%

7.66%

+35.88%

Volatility (1Y)

Calculated over the trailing 1-year period

72.75%

10.96%

+61.79%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

74.72%

14.38%

+60.34%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

73.52%

16.72%

+56.80%

Dividends

MRVI vs. SCHD - Dividend Comparison

MRVI has not paid dividends to shareholders, while SCHD's dividend yield for the trailing twelve months is around 3.26%.

PositionTTM20252024202320222021202020192018201720162015
MRVI
Maravai LifeSciences Holdings, Inc.		0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SCHD
Schwab U.S. Dividend Equity ETF		3.26%3.82%3.64%3.49%3.39%2.78%3.16%2.98%3.06%2.63%2.89%2.97%

Frequently Asked Questions

MRVI and SCHD have a correlation of 0.34, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

MRVI has higher volatility (24.44%) compared to SCHD (2.66%). In terms of maximum drawdown, MRVI dropped -97.16% vs SCHD's -33.37%.

SCHD currently has the higher Sharpe Ratio (2.49 vs 1.63), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for MRVI and SCHD

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer